Elotuzumab for the treatment of multiple myeloma

by Yucai Wang, Larysa Sanchez, David S. Siegel, Michael L. Wang
Published 2016-07-01

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

by Larysa Sanchez, Yucai Wang, David S. Siegel, Michael L. Wang
Published 2016-06-01

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

by Larysa Sanchez, Alexandra Dardac, Deepu Madduri, Shambavi Richard, Joshua Richter
Published 2021-01-01

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma

by Larysa Sanchez, Joshua Richter, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Lowena Tam, Daniel Verina, Ajai Chari
Published 2021-01-01